Second breast cancer following negative breast MRI: Analysis by interval from surgery and risk factors

Objectives This study aims to compare outcomes following a negative surveillance MRI study by surgery-MRI interval and investigate factors associated with second breast cancers in women with a personal history of breast cancer (PHBC). Methods This retrospective study included 1552 consecutive women (mean age, 53 years) with a PHBC and a negative prevalence surveillance breast MRI result between August 2014 and December 2016. The incidence and characteristics of second breast cancers were reviewed and compared according to surgery-MRI interval (< 3 years vs ≥ 3 years). Logistic regression analysis was used to investigate associations with clinical-pathologic characteristics. Results Twenty-five second breast cancers occurred after negative MRI. The incidence of second breast cancers or local-regional recurrence did not significantly differ by surgery-MRI interval. The median intervals between MRI to second breast cancer detection showed no significant difference between the two groups (surgery-MRI interval <3 years vs. ≥ 3 years). Two node-positive second breast cancers were detected in the group with <3 years interval. BRCA mutation status, receipt of breast-conserving surgery, and adjuvant chemotherapy (all p < .05) were significant factors associated with the development of second breast cancers. Conclusion Outcomes following a negative surveillance MRI did not differ by surgery-MRI interval. BRCA mutation status, receipt of breast-conserving surgery and adjuvant chemotherapy were independently associated with the risk of developing second breast cancers after negative surveillance MRI.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2024-08-15
DOI
https://doi.org/10.1371/journal.pone.0306828
Citations
1
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Second breast cancer following negative breast MRI: Analysis by interval from surgery and risk factors

Miribi Rho, Vivian Youngjean Park, Jung Hyun Yoon, Min Jung Kim et al.
1 citations
PLoS ONE
Breast Cancer Treatment Studies
0.29
article

Second breast cancer following negative breast MRI: Analysis by interval from surgery and risk factors

Miribi Rho, Vivian Youngjean Park, Jung Hyun Yoon, Min Jung Kim, Yo‐Han Joo
article en
1 citations

Abstract

Objectives This study aims to compare outcomes following a negative surveillance MRI study by surgery-MRI interval and investigate factors associated with second breast cancers in women with a personal history of breast cancer (PHBC). Methods This retrospective study included 1552 consecutive women (mean age, 53 years) with a PHBC and a negative prevalence surveillance breast MRI result between August 2014 and December 2016. The incidence and characteristics of second breast cancers were reviewed and compared according to surgery-MRI interval (< 3 years vs ≥ 3 years). Logistic regression analysis was used to investigate associations with clinical-pathologic characteristics. Results Twenty-five second breast cancers occurred after negative MRI. The incidence of second breast cancers or local-regional recurrence did not significantly differ by surgery-MRI interval. The median intervals between MRI to second breast cancer detection showed no significant difference between the two groups (surgery-MRI interval <3 years vs. ≥ 3 years). Two node-positive second breast cancers were detected in the group with <3 years interval. BRCA mutation status, receipt of breast-conserving surgery, and adjuvant chemotherapy (all p < .05) were significant factors associated with the development of second breast cancers. Conclusion Outcomes following a negative surveillance MRI did not differ by surgery-MRI interval. BRCA mutation status, receipt of breast-conserving surgery and adjuvant chemotherapy were independently associated with the risk of developing second breast cancers after negative surveillance MRI.

PLoS ONEVol. 19(8)
Yonsei University (KR)
Korea Medical Device Development Fund, National Research Foundation, Yonsei University, Ministry of Trade, Industry and Energy, Ministry of Food and Drug Safety, National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Yonsei University College of Medicine
Good health and well-being
Openalex Percentile: Top 40%
Breast Cancer Treatment Studies
0.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.